<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New licensed indications for Advocate</title><link>/b/veterinary-news/posts/24457</link><description> Bayer Animal Health has obtained two new licensed indications for its antiparasiticide, Advocate. 
 The first is that the product is now licensed for the treatment of Crenosoma vulpis using a single dose. The second is that in addition to the existing</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>